Comparison of High-Flow Nasal Cannula with Conventional Oxygen Therapy in Patients with Hypercapnic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

References

• Khakban A, Sin DD, FitzGerald JM, et al. The projected epidemic of chronic obstructive pulmonary disease hospitalizations over the next 15 years. a population-based perspective. Am J Respir Crit Care Med. 2017;195(3):287–291. doi:10.1164/rccm.201606-1162PP
   PubMed Web of Science ®Google Scholar
• Nagata K, Horie T, Chohnabayashi N, et al. Home high-flow nasal cannula oxygen therapy for stable hypercapnic COPD: a randomized trial. Am J Respir Crit Care Med. 2022;206(11):1326–1335. doi:10.1164/rccm.202201-0199OC
   PubMed Web of Science ®Google Scholar
• Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. doi:10.1183/13993003.02426-2016
   PubMed Web of Science ®Google Scholar
• Li X, Tang X, Wang R, et al. High-flow nasal cannula for chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure: a randomized, controlled trial. Int J Chron Obstruct Pulmon Dis. 2020;15:3051‐3061. doi:10.2147/COPD.S283020
   Web of Science ®Google Scholar
• Disease CRGoNMVfCOP. Early use of non-invasive positive pressure ventilation for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial. Chin Med J. 2005;118(24):2034–2040.
   PubMed Web of Science ®Google Scholar
• Ringbaek TJ, Lange P. Trends in long-term oxygen therapy for COPD in Denmark from 2001 to 2010. Respir Med. 2014;108(3):511–516. doi:10.1016/j.rmed.2013.10.025
   PubMed Web of Science ®Google Scholar
• Rittayamai N, Phuangchoei P, Tscheikuna J, Praphruetkit N, Brochard L. Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study. Ann Intensive Care. 2019;9(1):122. doi:10.1186/s13613-019-0597-5
   PubMed Web of Science ®Google Scholar
• Fraser JF, Spooner AJ, Dunster KR, Anstey CM, Corley A. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016;71(8):759–761. doi:10.1136/thoraxjnl-2015-207962
   PubMed Web of Science ®Google Scholar
• Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–1215. doi:10.1164/rccm.201605-0916OC
   PubMed Web of Science ®Google Scholar
• Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019;45(5):563–572. doi:10.1007/s00134-019-05590-5
   PubMed Web of Science ®Google Scholar
• Storgaard LH, Hockey HU, Laursen BS, Weinreich UM. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018;13:1195–1205. doi:10.2147/COPD.S159666
   PubMed Web of Science ®Google Scholar
• Huang X, Du Y, Ma Z, et al. High-flow nasal cannula oxygen versus conventional oxygen for hypercapnic chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Clin Respir J. 2021;15(4):437–444. doi:10.1111/crj.13317
   PubMed Web of Science ®Google Scholar
• Longhini F, Pisani L, Lungu R, et al. High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure. Crit Care Med. 2019;47(6):E506–E511. doi:10.1097/CCM.0000000000003740
   PubMed Web of Science ®Google Scholar
• Xia J, Gu S, Lei W, et al. High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial. Crit Care. 2022;26(1):109. doi:10.1186/s13054-022-03973-7
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi:10.1186/1471-2288-14-135
   PubMed Web of Science ®Google Scholar
• Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805. doi:10.1177/0962280216669183
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care. 2018;22(1):180. doi:10.1186/s13054-018-2107-9
   PubMedGoogle Scholar
• Nagata K, Kikuchi T, Horie T, et al. Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease. A multicenter randomized crossover trial. Ann Am Thorac Soc. 2018;15(4):432‐439. doi:10.1513/AnnalsATS.201706-425OC
   PubMed Web of Science ®Google Scholar
• Storgaard L, Hockey H, Weinreich U. Development in PaCO 2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled trial. BMJ Open Respir Res. 2020;7(1):e000712. doi:10.1136/bmjresp-2020-000712
   PubMed Web of Science ®Google Scholar
• Yang S, Guizhen Z, Zhen L, et al. Effect of high-flow nasal cannula oxygen therapy on diaphragmatic function in patients with acute exacerbation of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(5):551–555. doi:10.3760/cma.j.issn.2095-4352.2019.05.006
   PubMedGoogle Scholar
• Pisani L, Astuto M, Prediletto I, Longhini F. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology. 2019;25(6):348–354. doi:10.1016/j.pulmoe.2019.08.001
   PubMed Web of Science ®Google Scholar
• Roca O, Hernández G, Díaz-Lobato S, Carratalá JM, Gutiérrez RM, Masclans JR. Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care. 2016;20(1):109. doi:10.1186/s13054-016-1263-z
   PubMedGoogle Scholar
• Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med. 2011;37(11):1780–1786. doi:10.1007/s00134-011-2354-6
   PubMed Web of Science ®Google Scholar
• Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intens Care. 2015;3(1):15. doi:10.1186/s40560-015-0084-5
   PubMedGoogle Scholar
• Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009;103(6):886–890. doi:10.1093/bja/aep280
   PubMed Web of Science ®Google Scholar
• Lyu R, Wang W, Wang W, Liu N, Xiao J, Li X. Effect of humidified high-flow nasal cannula oxygen therapy on respiratory function recovery in stable COPD patients. Am J Transl Res. 2022;14(6):4074–4081.
   PubMed Web of Science ®Google Scholar
• Ruangsomboon O, Dorongthom T, Chakorn T, et al. High-flow nasal cannula versus conventional oxygen therapy in relieving dyspnea in emergency palliative patients with do-not-intubate status: a randomized crossover study. Ann Emerg Med. 2020;75(5):615–626. doi:10.1016/j.annemergmed.2019.09.009
   PubMed Web of Science ®Google Scholar
• Azoulay E, Lemiale V, Mokart D, et al. Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA. 2018;320(20):2099–2107. doi:10.1001/jama.2018.14282
   PubMed Web of Science ®Google Scholar
• Fu C, Liu X, Zhu Q, et al. Efficiency of high-flow nasal cannula on pulmonary rehabilitation in COPD patients: a meta-analysis. Biomed Res Int. 2020;2020:7097243. doi:10.1155/2020/7097243
   PubMed Web of Science ®Google Scholar
• Mauri T, Alban L, Turrini C, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med. 2017;43(10):1453–1463. doi:10.1007/s00134-017-4890-1
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Chen YH, Huang CC, Lin HL, Cheng SL, Wu HP. Effects of high flow nasal cannula on exercise endurance in patients with chronic obstructive pulmonary disease. J Formosan Med Assoc. 2022;121(1 Pt 2):381–387. doi:10.1016/j.jfma.2021.05.018
   PubMed Web of Science ®Google Scholar